The 34 references in paper Zh. Mironova A., V. Тrofimov I., V. Vysochinskay V., E. Esaulenko V., А. Bogdanov А., D. Ghorab N., N. Кnyazev A., V. Zarubaev V., М. Dubina V., Ж. Миронова А., В. Трофимов И., В. Высочинская В., Е. Эсауленко В., А. Богданов А., Д. Гораб Н., Н. Князев А., В. Зарубаев В., М. Дубина В. (2014) “Перспективы лечения бронхиальной астмы с использованием малых интерферирующих РНК // Perspectives of bronchial asthma treatment using small interfering RNA” / spz:neicon:pulmonology:y:2012:i:4:p:100-105

1
Gibeon D.S., Campbell D.A., Menzies-Gow.The systematic assessment of difficult-to-treat asthma: why do it? Clin. Pulm. Med. 2010; 17 (6): 255–259.
(check this in PDF content)
2
Федосеев Г.Б., Трофимов В.И., Петрова М.А.Многоликая бронхиальная астма: диагностика, лечение и профилактика. СПб.: Нордмед-Издат; 2011.
(check this in PDF content)
3
Чучалин А.Г. Клинические рекомендации по диагностике, лечению и профилактике бронхиальной астмы, одышки: Руководство для врачей. М.: НТЦ КВАНТ; 2005.
(check this in PDF content)
4
Лещенко И.В., Лежнина М.Б.Возможности контроля БА на современном уровне. Актуальные проблемы. Consilium Medicum 2009; экстравып. 2–5.
(check this in PDF content)
5
Петровский В.Ф., Огородова Л.М.Выбор фармакотерапии тяжелой БА. Пульмонология 2008; 3: 84–89.
(check this in PDF content)
6
Чучалин А Г. Бронхиальная астма. М.: Рус. врач; 2001.
(check this in PDF content)
7
Barnes P.J. Mechanisms and resistance in glucocorticoid control of inflammation. J. Steroid Biochem. Mol. Biol. 2010; 120: 76–85.
(check this in PDF content)
8
Adcock I.M., Barnes P.J. Molecular mechanisms of corticosteroid resistance. Chest 2008; 134: 394–401.
(check this in PDF content)
9
Пузырев В.П., Огородова Л.М.Генетика бронхолегочных заболеваний / Под ред. А.Г. Чучалина. М.: Атмосфера; 2010.
(check this in PDF content)
10
Миронова Ж.А., Трофимов В.И., Янчина Е.Д., Дубина М.В. Ассоциация вариантов гена бета2-адренорецептора (ADRB2) и бронхиальной астмы. Пробл. клин. мед. 2009, 1 (19): 58–61.
(check this in PDF content)
11
Миронова Ж.А., Трофимов В.И., Янчина Е.Д. и др. Мутация С3435Т в гене множественной лекарственной устойчивости MDR1 – фармакогенетический маркер тяжелого течения бронхиальной астмы. Рос. аллергол. журн. 2012; 2: 9–12.
(check this in PDF content)
12
Sigurs N., Bjarnason R., Sigurbergsson F. et al.Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000: 161 (5): 1501–1507.
(check this in PDF content)
13
Gern J.E., Busse W.W. Relationship of viral infections to wheezing illnesses and asthma. Nature Rev. Immun. 2002; 2 (2): 132–138.
(check this in PDF content)
14
Федосеев Г.Б., Трофимов В.И.Бронхиальная астма. СПб.: Нордмед-Издат; 2006.
(check this in PDF content)
15
Mahalingam S., Friendland J.S., Heise M.T. Chemokines and viruses: friends or foes?. http//timi.trends.com.2003
(check this in PDF content)
16
Message S.D., Laza-Stanca V., Mallia P. et al.Rhinovirusinduced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl Acad. Sci. USA 2008; 105 (36): 13562–13567.
(check this in PDF content)
17
Panickar J., Lakhanpaul M., Lambert P.C. et al.Oral prednisolone for preschool children with acute virus-induced wheezing. N. Engl. J. Med. 2009; 360 (4): 329–338.
(check this in PDF content)
18
Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am. J. Respir. Crit. Care Med. 2001: 163: 2–6.
(check this in PDF content)
19
Lüsebrink J., Schildgen V., Schildgen O. Novel therapies for an old virus: treatment of RSV infections in the 21st Century. Exp. Rev. Anti Infect. Ther. 2009; 7 (9): 1125–1129.
(check this in PDF content)
20
Popescu F.D. Antisense- and RNA interference-based therapeutic strategies in allergy. J. Cell. Mol. Med. 2005; 9: 840–853.
(check this in PDF content)
21
Janssen L.J. Asthma therapy: how far have we come, why did we fail and where should we go next. Eur. Respir. J. 2009. 33: 11–20.
(check this in PDF content)
22
Fire A., Xu S., Montgomery M. K. et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998: 391 (6669): 806–811.
(check this in PDF content)
23
Dykxhoorn D.M., Novina C.D., Sharp P.A.Killing the messenger: short RNAs that silence gene expression. Nature Rev. Mol. Cell Biol. 2003; 4 (6): 457–467.
(check this in PDF content)
24
Cullen B.R. RNAi the natural way. Nature Genet. 2005; 37 (11): 1163–1165.
(check this in PDF content)
25
Ambros V. The functions of animal microRNAs. Nature 2004; 431 (7006): 350–355.
(check this in PDF content)
26
Winston W.M., Molodowitch C., Hunter C.P.Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science 2002; 295 (5564): 2456–2459.
(check this in PDF content)
27
Guo J., Fu Y.C., Becerra C.R.Dissecting role of regulatory factors in NF-kappaB pathway with siRNA. Acta Pharmacol. Sin. 2005; 26: 780–788.
(check this in PDF content)
28
Rippmann J.F., Schnapp A., Weith A. et al. Gene silencing with STAT6 specifi c siRNAs blocks eotaxin release in IL-4 / TNFalpha stimulated human epithelial cells. FEBS Lett. 2005; 579: 173–178.
(check this in PDF content)
29
Ulanova M., Marcet-Palacios M., Munoz S. et al.Involvement of Sykkinase in TNF-induced nitric oxide production by airway epithelial cells. Biochem. Biophys. Res. Commun. 2006; 351: 431–437.
(check this in PDF content)
30
Mattes J., Yang M., Foster P.S. Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specifi c regulation of gene function. Am. J. Respir. Cell. Mol. Biol. 2007; 36: 8–12.
(check this in PDF content)
31
Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy: a review. Virus Genes 2006; 33 (2): 235–252.
(check this in PDF content)
32
Акимов В.С., Хаитов М.Р., Файзулоев Е.Б. и др. Подавление репродукции респираторно-синцитиального вируса методом siRNA. Вопр. вирусол. 2007; 2: 8–12.
(check this in PDF content)
33
Bitko V., Musiyenko A., Shulyayeva O., Barik S.Inhibition of respiratory viruses by nasally administered siRNA. Nature Med. 2005; 11 (1): 50–55.
(check this in PDF content)
34
DeVincenzo J., Lambkin-Williams R., Wilkinson T. et al. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc. Natl Acad. Sci USA 2010; 107 (19): 8800–8805.
(check this in PDF content)